The Financial Comet
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

The Financial Comet

Politics

Dr. Oz becomes next head of Medicare and Medicaid Services following approval from full Senate

by admin April 4, 2025
April 4, 2025
Dr. Oz becomes next head of Medicare and Medicaid Services following approval from full Senate

Dr. Mehmet Oz will serve as the next administrator of the Centers for Medicare and Medicaid Services after the full Senate voted along party lines to confirm his nomination on Thursday. 

The former daytime TV doctor turned politician will be in charge of nearly $1.5 trillion in federal healthcare spending. His duties will entail overseeing Medicare, Medicaid and the Children’s Health Insurance Program (CHIP), including directing decisions related to how the government covers procedures, hospital stays and medication, as well as the reimbursement rates at which healthcare providers get paid for their services.   

Medicare is a federal healthcare program for seniors aged 65 and up, and currently provides coverage to about 65 million Americans, according to the Center for Medicare Advocacy. Medicaid, a public health assistance program for people with low incomes, covers roughly 72 million Americans, according to Medicaid.gov. Meanwhile, CHIP, which provides free or low-cost health coverage for eligible low-income children and family members, assists around 7.2 million individuals. 

A graduate of Harvard University, Oz received medical and business degrees from the University of Pennsylvania. He is a former heart surgeon who saw his fame rise through his appearances on daytime television, including ‘The Oprah Winfrey Show,’ and 13 seasons of ‘The Dr. Oz Show.’

Oz later transitioned into politics, launching an unsuccessful bid for Pennsylvania’s open Senate seat in 2022. He lost to John Fetterman, then the state’s lieutenant governor.

‘Dr. Oz has a strong desire to modernize CMS and encourage healthy lifestyles for all Americans, including by focusing on the underlying causes of chronic disease and implementing innovative technologies,’ Senate Finance Committee Chairman Sen. Mike Crapo, R-Idaho, said Thursday.

Crapo, who led Oz’s nomination process at the committee level, commended Oz for his ‘diligence and accessibility’ throughout the process, including his willingness to answer ‘hundreds’ of questions for the record.

Those questions came from both Republicans and Democrats. They included asking about Oz’s stance on abortion, transgender medical treatments, Medicare privatization, prescription drug pricing and more. Potential financial conflicts of interest were also a concern among Democratic lawmakers throughout Oz’s confirmation process. Oz has committed to divesting any holdings that may pose an issue. 

Thursday’s confirmation comes as the Trump administration continues to work to finalize the rest of its political appointments, including notably the president’s pick to be the next United Nations ambassador and his pick for director of the Consumer Financial Protection Bureau. 

Per The Washington Post’s ‘political appointee tracker,’ there are currently still 233 nominees being considered by the Senate.

This post appeared first on FOX NEWS

previous post
Trump wants Musk to stay with administration, says DOGE found something ‘horrible’ today
next post
Here’s a closer look at Trump’s tariff plan: What to know about the new duties

Related Posts

Elon Musk’s budget-slashing hits political reality of suffering...

February 19, 2025

Greenland’s opposition party pushes closer US ties, independence...

March 11, 2025

New book details Obama’s strained relationship with Democratic...

April 5, 2025

Europeans meet with Iranian officials face-to-face for first...

July 26, 2025

Mexico sues Google for changing ‘Gulf of Mexico’...

May 10, 2025

Dems flood defense bill with far-left amendments aimed...

September 9, 2025

Direct aid to Israel should be phased out...

March 14, 2025

First lady Melania Trump’s new official portrait revealed

January 28, 2025

Dem bid to end Trump energy emergency squashed...

February 27, 2025

Grieving parents of American terror victim plead with...

July 26, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 2

      DeepSeek hit with large-scale cyberattack, says it’s limiting registrations

      January 28, 2025
    • 3

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 27, 2025
    • 4

      UnitedHealthcare taps company veteran Tim Noel as new CEO following Brian Thompson killing

      January 27, 2025
    • 5

      Bank of America CEO says financial industry will jump into crypto payments if regulators allow it

      January 23, 2025
    • 6

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • 7

      Lara Trump to host weekend show on Fox News

      February 7, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: thefinancialcomet.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 thefinancialcomet.com | All Rights Reserved